Newsroom

BOSTON--(BUSINESS WIRE)--VideaHealth, the leading dental AI platform, and Aspen Dental Management, Inc., one of the nation’s largest and fastest-growing dental support organizations, today announced a successful six-week rollout of VideaAI into every Aspen Dental practice. Building on the successful nationwide rollout of VideaHealth’s Clinical Assist platform, the partnership is one of the largest AI implementations in dentistry to date, marking the next phase of transforming chairside care. Fo...

DURHAM, N.C.--(BUSINESS WIRE)--HemoSonics LLC, a medical device company focused on acute bleeding management, today announced that its Quantra® Hemostasis System for Obstetric Procedures is one of the top three finalists in the Women’s Health and Reproductive Innovations category of the world-renowned 2026 Edison Awards. The Company’s point-of-care solution received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded use of its Quantra Hemostasis System with QStat® Ca...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on February 24, 2026, at 8:30 a.m. ET to discuss the results. To participate in the call, please dial 800-274-7083 (domestic) or 203-518-9786 (international), and reference passcode HRMYQ425. It...

ATLANTA--(BUSINESS WIRE)--William Mills Agency, the nation’s leading fintech public relations and marketing firm, has been selected by CD Valet, a digital marketplace that connects consumers with the best verified, high-yield CD rates nationwide, helping community financial institutions effectively attract new deposits. Launched by Seattle Bank, CD Valet was created to solve a critical gap in the market: community financial institutions struggle to make their CD rates visible, despite often bei...

ANN ARBOR, Mich.--(BUSINESS WIRE)--The U.S. economy faces a witches' brew of destructive macro and microeconomic problems: increasing customer switching costs and complaints, with stagnating satisfaction. Paradoxically, customer defections are down — not up. These are not signs of a healthy economy. Over the past six months, the American Customer Satisfaction Index (ACSI®) has remained unchanged — even at the first decimal. From a sample of about 200,000 customers, the national ACSI score holds...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

NIAGARA FALLS, N.Y.--(BUSINESS WIRE)--Altera Digital Health, a global health IT leader, today announced that KPC Health will deploy the Paragon® Denali electronic health record (EHR) at its seven hospitals based in Southern California. With three KPC Health facilities currently leveraging Paragon, the system-wide implementation of Paragon Denali will help reduce IT burden, streamline financials and improve user satisfaction due to the EHR’s cloud-based, containerized architecture. Serving nearl...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with semiconductor chip-based ultrasound devices, software and AI, today announced that its Butterfly iQ+/iQ3 and Compass AI™ ultrasound solution have achieved GovRAMP and TX-RAMP Authorizations. The certifications authorize the Company to sell cloud services to all state and local government agencies, including in the state of Texas. GovRA...

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorder, today announced it will host a live webinar on February 17, 2026 at 3:00 p.m. ET/ 12:00 p.m. PT exploring the evolving ALS treatment landscape. Titled ‘Inside the Evolving ALS Landscape: Biology, Innovation, and Clinical Progress’, the webinar will explore re...

TULSA, Okla.--(BUSINESS WIRE)--Williams Reports 2025 Financial Results...